Charles W. Taylor

5.5k total citations · 1 hit paper
82 papers, 4.3k citations indexed

About

Charles W. Taylor is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Charles W. Taylor has authored 82 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 19 papers in Oncology and 9 papers in Organic Chemistry. Recurrent topics in Charles W. Taylor's work include Genomics and Chromatin Dynamics (8 papers), Glycosylation and Glycoproteins Research (8 papers) and RNA and protein synthesis mechanisms (7 papers). Charles W. Taylor is often cited by papers focused on Genomics and Chromatin Dynamics (8 papers), Glycosylation and Glycoproteins Research (8 papers) and RNA and protein synthesis mechanisms (7 papers). Charles W. Taylor collaborates with scholars based in United States, United Kingdom and Sweden. Charles W. Taylor's co-authors include Gillian Paine-Murrieta, Lynn C. Yeoman, Harris Busch, H. Busch, William S. Dalton, S. E. Salmon, Robert J. Gillies, Thomas M. Grogan, Wesley C. Starbuck and TP Miller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Charles W. Taylor

80 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

1989 478 citations William S. Dalton, Thomas M. Grogan et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Charles W. Taylor

Since Specialization

Citations

This map shows the geographic impact of Charles W. Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles W. Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles W. Taylor more than expected).

Fields of papers citing papers by Charles W. Taylor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles W. Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles W. Taylor. The network helps show where Charles W. Taylor may publish in the future.

Co-authorship network of co-authors of Charles W. Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Charles W. Taylor. A scholar is included among the top collaborators of Charles W. Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles W. Taylor. Charles W. Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase II evaluation of interleukin-4 in patients with non-Hodgkinʼs lymphoma: a Southwest Oncology Group Trial 2000 ·Anti-Cancer Drugs ·Charles W. Taylor, Michael LeBlanc, Richard I. Fisher, Dennis F. Moore, Ralph W. Roach, Laurence Elias, Thomas P. Miller	14
2	The Cambridge Companion to Early Greek Philosophy 1999 ·Cambridge University Press eBooks ·A. A. Long, A. A. Long, Jaap Mansfeld, Keimpe Algra, Carl A. Huffman, Edward Hussey, David Sedley, Richard McKirahan, Daniel W. Graham, Charles W. Taylor, (unknown), J. H. Lesher, André Laks, Mario Vegetti, Paul Woodruff, (unknown), Glenn W. Most	63
3	Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P magnetic resonance spectroscopy 1999 ·Biochemical Pharmacology ·Natarajan Raghunand, María I. Altbach, Robert van Sluis, Brenda Baggett, Charles W. Taylor, Zaver M. Bhujwalla, Robert J. Gillies	78
4	Enhancement of chemotherapy by manipulation of tumour pH 1999 ·British Journal of Cancer ·Natarajan Raghunand, Xi He, Robert van Sluis, (unknown), Brenda Baggett, Charles W. Taylor, Gillian Paine-Murrieta, Denise J. Roe, Zaver M. Bhujwalla, Robert J. Gillies	272
5	Wortmannin inhibits the growth of mammary tumors despite the existence of a novel wortmannin-insensitive phosphatidylinositol-3-kinase 1999 ·Cancer Chemotherapy and Pharmacology ·(unknown), Gillian Paine-Murrieta, Charles W. Taylor, Garth Powis	36
6	Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study. 1998 ·Journal of Clinical Oncology ·Charles W. Taylor, (unknown), William S. Dalton, Silvana Martino, (unknown), James N. Ingle, Nicholas J. Robert, G. T. Budd, Jorge C. Paradelo, Ronald B. Natale, James D. Bearden, J A Mailliard, C. Kent Osborne	142
7	In vitro effects of simulated gastric juice on swallowed metal objects: implications for practical management 1997 ·Gastrointestinal Endoscopy ·(unknown), (unknown), Charles W. Taylor, (unknown), Raphael S. Chung	2
8	Amifostine protects normal tissues from paclitaxel toxicity while cytotoxicity against tumour cells is maintained 1997 ·European Journal of Cancer ·Charles W. Taylor, (unknown), Alan F. List, Daniel Fernandes, Gillian Paine-Murrieta, Cynthia S. Johnson, Robert L. Capizzi	53
9	Randomized Trial of Adjuvant Human Interferon Gamma Versus Observation in High-Risk Cutaneous Melanoma: a Southwest Oncology Group Study 1995 ·JNCI Journal of the National Cancer Institute ·FL Meyskens, Kenneth J. Kopecky, Charles W. Taylor, R. Dirk Noyes, Ralph J. Tuthill, E. M. Hersh, Lynn G. Feun, James H. Doroshow, Lawrence E. Flaherty, (unknown)	83
10	Suppression of Human Lymphoma Development in the Severe Combined Immune-Deficient Mouse by Imexon Therapy 1993 ·Journal of Immunotherapy ·Evan M. Hersh, Thomas M. Grogan, (unknown), Charles W. Taylor	9
11	Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group. 1993 ·Journal of Clinical Oncology ·David R. Gandara, John Crowley, Robert B. Livingston, Edith A. Perez, Charles W. Taylor, Geoffrey R. Weiss, John R. Neefe, Laura F. Hutchins, Ralph W. Roach, Steven M. Grunberg	121
12	Sensitivity of nuclear c-myc levels and induction to differentiation-inducing agents in human colon tumor cell lines 1992 ·Cancer Letters ·Charles W. Taylor, (unknown), (unknown), Lynn C. Yeoman	32
13	Effects of Suramin on In Vitro Growth of Fresh Human Tumors 1992 ·JNCI Journal of the National Cancer Institute ·Charles W. Taylor, Rashid N. Lui, Paul T. Fanta, S. E. Salmon	39
14	Alteration of Human Tumor Cell Adhesion by High-Strength Static Magnetic Fields 1992 ·Investigative Radiology ·(unknown), (unknown), Charles W. Taylor, Constantin Job, (unknown), Anne E. Cress	31
15	Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: Report of three cases 1991 ·Investigational New Drugs ·Frank V. Fossella, Scott M. Lippman, David E. Seitz, David S. Alberts, Charles W. Taylor, E. Wiltshaw, Janet Hardy, Mary O’Brien, (unknown), Robert L. Wolen	2
16	A phase I and pharmacokinetic study of intravenous vinzolidine 1990 ·Investigational New Drugs ·Charles W. Taylor, (unknown), W. Satterlee, (unknown), (unknown), Mark T. Holdsworth, Patricia M. Plezia, D S Alberts	4
17	Clinical pharmacology of a novel diarylsulfonylurea anticancer agent. 1989 ·Journal of Clinical Oncology ·Charles W. Taylor, David S. Alberts, (unknown), W. Satterlee, Mark T. Holdsworth, Patricia M. Plezia, Yei Mei Peng, (unknown), Denise J. Roe, Marta Hamilton	38
18	High levels of doxorubicin in the tissues of a patient experiencing extravasation during a 4-day infusion 1989 ·Cancer ·Robert T. Dorr, Margaret S. Dordal, (unknown), Charles W. Taylor, (unknown)	10
19	Antigenically active nonhistone chromatin proteins in cancer cells. 1976 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Harris Busch, Lynn C. Yeoman, Rose K. Busch, John J. Jordan, (unknown), Charles W. Taylor, (unknown)	4
20	Structure of the glycine-rich, arginine-rich histone of the Novikoff hepatoma. 1970 ·PubMed ·Rajni K. Wilson, Wesley C. Starbuck, Charles W. Taylor, John J. Jordan, Harris Busch	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact